Please Wait
Applying Filters...
menu
    • menu
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Elapegademase-lvlr

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Everything You Need to Know About FDA’s Priority Review Vouchers
    Everything You Need to Know About FDA’s Priority Review Vouchers

    13 Feb 2019

    // Michael Mezher RAPS

    https://www.raps.org/regulatory-focus/news-articles/2017/12/regulatory-explainer-everything-you-need-to-know-about-fdas-priority-review-vouchers?utm_source=MagnetMail&utm_medium=Email%20&utm_campaign=RF%20Today%20%7C%2015%20February

    Michael Mezher RAPS
    13 Feb 2019
    Share Share
    Teva successfully used a rare pediatric PRV to speed the approval for Ajovy
    Teva successfully used a rare pediatric PRV to speed the approval for Ajovy

    21 Nov 2018

    // Zachary Brennan RAPS

    https://www.raps.org/regulatory-focus/news-articles/2017/12/regulatory-explainer-everything-you-need-to-know-about-fdas-priority-review-vouchers

    Zachary Brennan RAPS
    21 Nov 2018
    Share Share
    Leadiant gets FDA OK for bubble boy disease drug
    Leadiant gets FDA OK for bubble boy disease drug

    08 Oct 2018

    // Phil Taylor PM LIVE

    http://www.pmlive.com/pharma_news/leadiant_gets_fda_ok_for_bubble_boy_disease_drug_1254869

    Phil Taylor PM LIVE
    08 Oct 2018
    Share Share